SCHEMBL9038707

SCHEMBL9038707

CS(=O)(=O)O.Cc1cnc2c(c1)cc1c3c(cc([N+](=O)[O-])cc32)C(=O)N([C@H](C)CNC[C@@H](C)NC[C@@H](C)N2C(=O)c3cc([N+](=O)[O-])cc4c3c(cc3cc(C)cnc34)C2=O)C1=O

nearest known ligand 0.30

Known targets — ChEMBL curated mechanism

ABL1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB2AGTR1BCL2BCL2A1BCL2L1BCL2L10BCL2L2BCRBRAFCHRM1CHRNA10CHRNA9DRD1DRD2DRD3DRD4DRD5EGFRF2FLT1FLT4GCKGHSRGNRHRGRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BHTR1AHTR1BHTR1DHTR2AHTR2CHTR3AIDH2KDRKITMAOBMCL1MTTPPP4HBPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PIKFYVEROCK1ROCK2SLC18A2SLC6A2SLC6A3SLC6A4TACR1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8gyrAgyrBparCparEpol

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
FTO Q9C0B1 1/20 0.30
NTRK1 P04629 1/20 0.30
NGFR P08138 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9049021 1.00 FTO (0.30) FTONTRK1NGFR
SCHEMBL9113759 0.96 FTO (0.32) FTONTRK1NGFR
SCHEMBL9048246 0.92 FTO (0.33) FTONTRK1NGFR
SCHEMBL9115379 0.87 FTO (0.36) FTONTRK1NGFR
SCHEMBL9038069 0.86 FTO (0.44) FTONTRK1NGFR
SCHEMBL9113483 0.81 FTO (0.47) FTONTRK1NGFR
SCHEMBL9080330 0.78 MAPT (0.39) FTONTRK1NGFR
SCHEMBL9040517 0.78 MAPT (0.39) FTONTRK1NGFR
SCHEMBL9079560 0.77 FTO (0.41) FTONTRK1NGFR
SCHEMBL9041900 0.76 FTO (0.36) FTO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5585382-A ANTICARCINOGENIC AGENTS THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1996-12-17 US disclosed
EP-0705250-A1 BIS-IMIDE POLYCYCLIC AND HETEROCYCLIC CHROMOPHORES USEFUL AS TUMORICIDALS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1996-04-10 EP disclosed
US-5416089-A Antitumor agent THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1995-05-16 US disclosed
WO-1995000490-A1 BIS-IMIDE POLYCYCLIC AND HETEROCYCLIC CHROMOPHORES USEFUL AS TUMORICIDALS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1995-01-05 WO disclosed